 Adherence to treatment is crucial to the efficacy of sublingual immunotherapy of allergic diseases. GRAZAX is a registered drug in Europe, with established efficacy in the treatment of allergic rhinitis, which has to be taken daily by patients. This study was aimed to establish if a device with the characteristics of a mechanical dispenser Memozax could improve adherence to treatment in subjects with hay fever due to allergy to grass 